Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus

BACKGROUND: In consideration of the drug resistance and side effects associated with cytarabine, one of the most effective drugs for the treatment of acute myeloid leukemia (AML), there is a need for safer and effective strategies. METHODS: In the present investigation, we fabricated a new oncolytic...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jiamin, Wang, Shibing, Fan, Weimin, Li, Shuangshuang, Wu, Yi, Mou, Xiaozhou, Wang, Jianchao, Tong, Xiangmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199215/
https://www.ncbi.nlm.nih.gov/pubmed/30410347
http://dx.doi.org/10.2147/OTT.S172037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199215/
https://www.ncbi.nlm.nih.gov/pubmed/30410347
http://dx.doi.org/10.2147/OTT.S172037

Ejemplares similares